Given a document and an entity the task is to select the author's sentiment towards the entity. Sentiments can be Positive, Neutral and Negative. Select Positive if the article expresses a positive view towards the given entity or praises its quality or skills. Select Neutral if the document expresses no clear view towards the entity or has equal amounts of positive and negative statements or expressing some fact/quote by someone else. Select Negative if the article expresses a negative view towards like harsh remarks, criticizing entities action/decision etc. Note that URLs in the text have been replaced with [Link].

[EX Q]: What is the sentiment of the following document towards the entity Gordon MacDonald ? Allegations of sexual misconduct against three Dartmouth College professors have resulted in a multi-agency criminal investigation  says  New Hampshire Attorney General Gordon MacDonald .
After  MacDonald 's office contacted Dartmouth  he says  "we have learned from the College that it has received allegations of sexual misconduct."
A multi-agency investigation into the case is now under way  which  MacDonald  says includes both  his  office and the Office of the Grafton County Attorney  along with the New Hampshire State Police  the Grafton County Sheriff's Department and the Hanover Police Department.
 MacDonald 's press release about the case included contact information for investigators on the case  along with lists of services for anyone affected by sexual violence.
[EX A]: Positive

[EX Q]: What is the sentiment of the following document towards the entity Ablynx ? PARIS/LONDON (Reuters) - French drugmaker Sanofi has agreed to buy  Belgian biotech company Ablynx  for 3.9 billion euros ($4.8 billion)  beating Novo Nordisk and marking its second big deal this month after buying Bioverativ.
The deal is a further sign of accelerating merger and acquisition (M&A) activity in the global biotech sector and comes after  Ablynx  rejected a 2.6 billion euro offer from Denmark’s Novo Nordisk.
Sanofi said on Monday it would pay 45 euros per share in cash for Ablynx  a premium of 21 percent over its closing price on Friday - and more than double the price before Novo went public with its initial bid.
Novo Nordisk conceded defeat  saying it did not intend to make a revised offer for Ablynx  which is developing a prized experimental drug for a rare blood disorder.
Sanofi said  Ablynx  would boost long-term value for  its  shareholders  while the takeover was expected to have a neutral impact on Sanofi’s business earnings per share (EPS) in 2018 and 2019.
Sanofi is already one of  Ablynx ’s big pharma partners  after striking a deal in July 2017 to find new treatments for inflammatory diseases.
By buying the company outright it will now get access to  Ablynx ’s most promising asset  the experimental drug caplacizumab for treating the rare bleeding disorder acquired thrombotic thrombocytopenic purpura.
Sanofi will be able to use its existing infrastructure and the recently acquired platform from Bioverativ to help to commercialize caplacizumab. It will also benefit from some of the other drugs  Ablynx  is working on  such as an infant anti-viral treatment  that would not have fitted within Novo Nordisk.
Berenberg analysts said  Ablynx  was a good fit but they estimated the deal would generate no more than a 4 percent return on invested capital  assuming caplacizumab sales of around 400 million euros by 2023.
The Danish group has sat out previous rounds of M&A in the drugs sector to focus on its core diabetes business but it now needs to find new products for its struggling smaller biopharmaceutical unit  where Ablynx would have been a good fit.
Morgan Stanley and Lazard advised Sanofi on the deal while JP Morgan advised Ablynx.
[EX A]: Positive

[EX Q]: What is the sentiment of the following document towards the entity Carles Puigdemont ? BRUSSELS/MADRID/BARCELONA (Reuters) - Sacked Catalonia leader Carles Puigdemont and four associates turned themselves in to Belgian police on Sunday  following Spainâs issuing of an arrest warrant for rebellion and sedition.
FILE  PHOTO - Sacked Catalan President Carles Puigdemont  makes a statement in this still image from video calling for the release of "the legitimate government of Catalonia"  after a Spanish judge ordered nine Catalan secessionist leaders to be held in custody pending a potential trial over the region's independence push  in Brussels  Belgium  November 2  2017. TV3 via REUTERS TV
All are wanted by Madrid for actions related to the push for the regionâs secession from Spain.  Puigdemont  has become the public face of that move for independence.
 Puigdemont  traveled to Belgium shortly after Madrid took control. On Sunday morning   Puigdemont  and four of his former councillors presented themselves to police in Brussels.
[EX A]:
Neutral